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Introduction
Secretin (SCT), a brain-gut peptide belonging to the secretin/vasoactive intestinal peptide/glucagon peptide family, functions to stimulate secretion of bicarbonate, electrolytes and water from pancreatic ductal epithelial cells [1] , while its effects on other gastrointestinal tissues including intestine [2] , stomach [3] and liver [4] were also suggested. Recently, the neuroactive functions of secretin were studied. It was suggested that in the cerebellum, secretin acts as a retrograde messenger to facilitate GABA release from the presynaptic basket cells, either directly or indirectly via an unknown glutamate source, resulting in potentiating evoked inhibitory postsynaptic currents (IPSCs) in Purkinje cells [5, 6] . Recent evidences have suggested that SCT is potentially a neurohypophysial factor [7] . SCT and its receptor (SCTR) overlap with the functions of angiotensin II (ANGII), and more importantly, are needed in mediating the central actions of ANGII-induced responses [8] .
The activities of secretin are mediated via a class II G protein-coupled receptor, secretin receptor (SCTR). Using human pancreatic ductal carcinoma (PANC-1) and bovine pancreatic ductal (BPD-1) cells as models, we have previously identified a 106-bp core promoter element (-263 to -158, relative to the ATG start codon) in the 5' flanking region of the human secretin receptor (hSCTR) gene [9] . This core promoter is controlled by the competitive binding of specificity protein 1 and 3 (Sp1 and Sp3) with two functional GC boxes (-240 to -226 and -203 to -194) . In addition, the methylation status of CpG dinucleotides in the CpG island which overlaps with the core promoter was also found to be a critical factor to mediate the cell-specific expression of the hSCTR [10] .
To understand further the spatial and temporal expression of hSCTR, in this report, we sought to investigate the functions of a putative neuron restrictive silencer element (NRSE) located downstream (-83 to -67, relative to ATG) of the hSCTR core promoter. NRSE, also known as repressor element-1 (RE-1) with a consensus sequence "NTYAGMRCCNNRGMSAG" [11] , was initially identified to regulate a number of neuron-specific genes by repressing their expressions in non-neural tissues [12] . Recently, NRSE is regarded a common repressor element as it can suppress an increasing number of non-neuronal genes. A genome-wide search indicated the presence of about 1,800 putative NRSE sites in both human and mouse genomes [11] .
The protein factor that interacts with NRSE is neuron-restrictive silencer factor (NRSF), which is a member of the zinc-finger GLi-Krüppel family [13] . There are three domains in NRSF: a Krüppel-type zinc-finger for binding NRSE, an N-terminal repressor domain for interacting with SIN3 transcription regulator (Sin3), and a C-terminal repressor domain for recruiting the corepressor element 1 silencing transcription factor (CoREST). Both Sin3 and CoREST interact with histone deacetylase containing complex to deacetylate core histone proteins, and as a consequence, they work together to silence target genes by forming condensed chromatin structures and mediates developmental stage-specific gene expression [14, 15, 16] . An in silico analysis indicates that all members of the secretin receptor family contain at least one putative NRSE-like motif in their 5' flanking regions [17] .
With the knowledge that most of NRSF-regulated genes also possess GC-boxes in their promoter regions [18, 19] , for this reason, the functional relationships between Sp-protein(s) and NRSF in controlling hSCTR expression was investigated. Findings reported here not only provide crucial information regarding the cell-specific expression of hSCTR, but also are applicable to the understanding of other GC-box/NRSF co-regulated genes, including several members of the secretin receptor family.
Materials and Methods

Cell culture
All cell lines were purchased from American Type Culture Collection (ATCC).
PANC1-1 cells were cultured in Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Carlsbad, CA) with 10% FBS. PC12 cells were cultured in DMEM with 10% horse serum and 5% fetal bovine serum (FBS). All cells were cultured at 37°C with 5% CO 2 in a medium supplemented with 100 U/ml penicillin G and 100 µg/ml streptomycin (Invitrogen).
Plasmid construction
Cloning of the hSCTR promoter was described previously [9] . The plasmid p263/158 (-263 to -158 relative to the ATG start codon) was generated by exonuclease III/S1 nuclease digestion (Amersham Pharmacia, Arlington Heights, IL) followed by cloning into the Mlu I/Xho I sites of the pGL-2 basic vector (Promega Corp, Madison, WI). The region -263/-46 was obtained by PCR amplification of human genomic DNA and then subcloned into the Mlu I/Xho I sites of the pGL2 basic vector (Stratagene, La Jolla, CA). Expression vectors, Sp1/CMV. Sp3/CMV and Sp4/CMV were kindly provided by Prof. C. Paya (Mayo Clinic, Rochester, US). The NRSF expression vector, REEX1/CMV, and the dominant negative expression vector, p73/CMV, were gifts from Dr. Mandel (State University of New York) [20] . The potential shRNA target sites of human NRSF was determined using the Ambion design program (Ambion, CA), and the sequences were BLAST-confirmed for specificity. Sense and antisense oligos were annealed in an annealing buffer (100 mM potassium acetate, 30 mM HEPES (pH 7.4) and 2 mM magnesium acetate) at 90°C for 3 min, followed by incubation at 37°C for 1 h. The annealed DNA was cloned into the Apa I/Hind III sites of pSilencer 1.0-U6 shRNA expression vector (Ambion) for constructing shNRSF vector. As a negative control, siControl (Ambion) with a sequence that shares no significant identity to any known gene sequence was used.
PCR-linker Scanning Mutagenesis
Site-directed mutagenesis was carried out by a three-step PCR method (Nelson & Long 1989), using mutagenic primers MA, MB, MC, MD, ME, M1, M2 or DM and universal primers GL2-MP, GL1 and MP ( Table 1 ). The region -263/-158 was initially subcloned into Mlu I/Xho I sites of pGL2, and this construct was used as a template for all PCR mutagenesis. Mutations introduced were subsequently confirmed by DNA sequencing.
Transient transfection assay
PANC-1 and PC12 cells were plated at a density 2.5 x 10 5 cells / 35 mm well (six-well plate, Costar). After 2 days incubation, promoter-luciferase construct and β-gal control vector were cotransfected into cells using the Genejuice reagent (Novagen, Darmstadt) according to the manufacturer's protocol. Cells were harvested 48 h after transfection and cell extracts were assayed for luciferase and β-galactosidase activities as described previously [21] . For in vitro functional studies, 2 days after plating, promoter constructs and various amounts of the expression vector (Sp1/CMV, Sp3/CMV, Sp4/CMV, REEX1, and p73) and/or shRNA vector in a total of 3.5 µg DNA (adjusted by pBluescript KS + ) were cotransfected into cells by
Genejuice reagent. The transfected cells were incubated for two more days before luciferase and β-galactosidase activities were determined.
Co-immunoprecipitation and gel mobility shift assay
PANC-1 nuclear extract was prepared as described before [22] , and was incubated with 2 µg of the appropriate antibodies (NRSF, Sp1, Sp3 and Sp4, Santa
Cruz Biotechnology, CA) for 2 h at 4 o C. Protein G-agarose beads (20 µl) were used to pull-down the Ab-Ag complex. Western blotting was performed essentially according to a protocol described earlier [23] . 
Chromatin immunoprecipitation (ChIP) assay
The ChIP assays were performed essentially according to Baek et al. [24] .
PANC-1 cells were cross-linked with 1% formaldehyde for 15 min at room temperature. Cells were harvested by centrifugation and resuspended in the lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris pH 8.1, 1 mM phenylmethylsulfonyl fluoride (PMSF), 1 µg/ml Aprotinin and 1.5 µg/ml Pepstatin A). After sonication in Sonifier 450 (Branson, Danbury, CT), 10 µg antibody and 20 µl Protein A/G plus agarose were added to precipitate the DNA-protein complex. Precipitated DNA-protein complex was washed in the ChIP buffer (0.1% SDS, 1% Triton X-100, 0.1% Na deoxycholate, 140 mM NaCl , 1 mM PMSF, 1 µg/ml Aprotinin and 1.5 µg/ml Pepstatin A) and eluted in the elution buffer (1% SDS and 0.1 M NaHCO 3 ).
The mixture was incubated at 65°C for 4 h to reverse the formaldehyde cross-linking.
Proteins were digested by proteinase K (200 µg/ml) at 45°C for 2 h and followed by phenol/CHCl 3 extraction. The extracted DNA was used for PCR using the primers showed in Table 1 . For real-time PCR analysis, the extracted DNA was amplified by the SYBR Green PCR Master Mix kit (Applied Biosystems, Foster City, CA) and the signal was detected by the iCycler iQ detection system (Bio-Rad, Hercules, CA). The percentage recovery was normalized by the Ct value from the input control.
Real-time quantitative reverse-transcription polymerase chain reaction (RT-PCR) analysis
Total RNAs from cells were isolated using the TriPure reagent (Roche Molecular Biochemicals, Switzerland) and reverse-transcribed (5 µg) by an oligo-dT primer and Superscript III (Invitrogen). One-tenth of the first strand cDNAs was used for real-time PCR analysis, in which secretin and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) levels were measured by an Assays on Demand System (ID:
Hs00161610_m1; Applied Biosystems) or Pre-developed Taq-man probe with the Taqman Universal Master Mix (Applied Biosystems) using the iCycler iQ detection system (Bio-Rad). Relative expression levels of transcripts were calculated by the 2 -ΔΔCt method [25] using GAPDH as the endogenous control.
Data analysis
Data from the transfection assays were shown as the means ± SEM of triplicate assays in at least three independent experiments. Data from quantitative PCR were shown as the means of ± SEM of duplicate assays in at least three independent experiments. All data were analyzed by one-way ANOVA and followed by Dunnett's test using the computer software PRISM (version 3.0, GraphPad Software Inc., San Diego, CA).
Results
Identification of a functional NRSE in the 5' flanking region of the hSCTR gene
In human and mouse SCTR genes, putative NRSE sites at -83/-67 and -314/-298, respectively, relative to the ATG codon were identified ( Figure 1A ). To initially investigate whether this motif is functional in hSCTR, several DNA fragments with different 3' regions (ranged from -158 to -1) were linked to the luciferase reporter gene for transient promoter assays using the human pancreatic PANC-1 cell as a model. Constructs with the core promoter and the putative NRSE (p-263/-45, p-263/-1) exhibited promoter activities significantly lower than that of the control (core promoter construct p-263/-158) ( Figure 1B ). To locate the repressor/silencer element, scanning mutants (MA to ME Figure 1C) were constructed, and among them, changes of NRSE sequences led to either complete or partial recovery in promoter function (MD: 101%; ME: 79% vs control p-263/-158). The importance of NRSE was then confirmed by mutating the core nucleotides [11] of the motif ( Figure 1D ). In this study, mutation of either 1 or 2 core nucleotides resulted in partial but significant recovery of promoter activities (M1: 49% recovery, M2: 71%, and DM: 56%). Taken together, the conserved NRSE is a functional motif that down regulates the hSCTR gene expression.
In vitro and in vivo interaction of NRSF with NRSE in the hSCTR gene
To identify the transcription factor(s) that interacts with the NRSE, initially, gel mobility shift assays were performed. Using an NRSE-I oligo, two specific DNA-protein complexes were observed in PANC-1 nuclear extract (complexes A and B, Figure 2A , lanes 2 to 4). These complexes were specific as only cold NRSE-I or NRSE consensus (rM4RE1) [11, 26, 27] In summary, gel mobility shift assays and ChIP assays showed the in vitro and in vivo interaction of NRSF with the hSCTR promoter.
Transcriptional down-regulation of hSCTR gene by NRSF
To investigate the in vivo roles of NRSF to repress hSCTR expression, an NRSF expression vector (REEX1) [20] was cotransfected with the NRSE-containing promoter construct p-263/-45 into PC12 cells. We used PC12 cells as these cells do not express endogenous NRSF [28] .
As shown in Figure 3A , over-expression of NRSF caused a significant and dose-dependent decrease in hSCTR promoter activity in PC12 cells. The hSCTR promoter activity was decreased 53% when 2.0 µg of REEX1 was transfected into PC12 cells. In the hSCTR expressing PANC-1 cells, over-expression of NRSF also led to a significant drop in hSCTR transcript levels ( Figure 3B ). By real-time
RT-PCR, a 64% decrease of hSCTR mRNA was observed when 2.0 µg NRSF vector was transfected into the cells. These data therefore confirmed that an increased expression of NRSF could down-regulate hSCTR promoter, leading to reduced in vivo transcript levels of hSCTR.
To better reflect the in vivo actions of NRSF, we sought to knock-down endogenous NRSF by a vector-based shRNA approach. The knock-down effect of the shRNA (shNRSF) on NRSF expression level was confirmed by Western blotting ( Figure 3E ). As shown in the figure, the increase of shNRSF vector in the transfection can significantly reduce the protein level of NRSF in the transfected PANC-1 cells.
By cotransfecting shNRSF with the promoter constructs, a significant augmentation of luciferase activity was observed only in the NRSE-containing promoter (p-263/-45:
2.7-fold against control with no shNRSF, Figure 3C ), but not in the core promoter 
NRSF-mediated transcriptional down-regulation is Sp1 dependent
As it has previously been shown that hSCTR is controlled by the Sp1/Sp3 ratio Figure 5A ), we found that, Sp4 consistently had no effect, while both Sp1 and Sp3 could activate the NRSE-containing promoter. More interestingly, the activities of Sp1 and Sp3 in the NRSE containing promoter were different from our previous [10] and also present ( Figure 5D ) studies with the core promoter (-263 to -158). When the core promoter was used, Sp1 was a stronger activator comparing with Sp3 ( Figure 5D , Sp1: 2.5-fold vs Sp3: 1.2-fold, respectively). However, when the NRSE-containing promoter was employed, Sp3 was a stronger activator on promoter activity (Fig 5B, Sp3: 3.7-fold vs Sp1: 2.2-fold). These data suggest differential functions of Sp1 and Sp3 in controlling hSCTR expression in the presence or absence of NRSF.
To investigate the mechanisms underlining the differential activities Sp1 and Sp3, we co-expressed Sp1 or Sp3 with NRSF or a dominant negative NRSF p73 [20] ( Figure 5B ). NRSF over-expression significantly reduced the Sp1-mediated activation (from 219% to 60.3% against p-263/-45), whereas over-expression of the dominant negative NRSF p73 had no effect (Fig 5B) . On the contrary, the Sp3-mediated transactivation was not significantly affected by NRSF or p73 (Fig 5B: lanes 7-9) . To confirm these observations, shNRSF was used to knockdown the endogenous NRSF in PANC-1 cells in normal and Sp-protein over-expressed conditions. In the absence and presence of Sp1, silencing of endogenous NRSF could up-regulate hSCTR promoter activity (Fig 5C: lanes 1-6) , while shNRSF seemed to exhibit no effect in Sp3-over-expressed cells (Fig 5C: lanes 7-9) . As a control, over-expressing or silencing of endogenous NRSF had little effects on the core-promoter without the NRSE ( Figure 5D ). Taken together, our data suggested that the differential functions of Sp1 and Sp3 is a result of the specific inhibition of NRSF on Sp1-mediated transactivation in the hSCTR promoter. It was previous reported that NRSF could recruit histone deacetylases (HDAC) to repress gene expression through chromatin remodeling. In this study, when a HDAC inhibitor (Trihostatin A, TSA) was employed, hSCTR promoter (-263/-45) activity was significantly increased in Sp1-(1.8-fold increase), but not Sp3-transfected cells ( Figure 6 ). In the control experiment, when the NRSE motif was removed from the promoter (DM), the TSA treatment did not show significant effects on the promoter activities after either Sp1 or Sp3 oeverexpression. Our present data, taken together, therefore suggest that NRSF, via its interactions with Sp1 and HDAC, functions to repress hSCTR gene.
Discussion
NRSF and cell-specificity of secretin receptor
Secretin receptor was previously considered to be localized to classical sites such as the pancreatic and biliary ductal cells. Now it has been demonstrated that secretin receptors are expressed in specific cell types in various parts of the brain [5, 29, 30] as well as peripheral tissues [31.32,33] . The spatial and temporal regulation of this receptor is the key to understanding secretin's physiology, but remains largely unknown. The present study provides new information regarding the transcriptional mechanisms controlling SCTR gene involving NRSF. NRSE was originally found in the 5' flanking region of the gene encoding the voltage-gated sodium type II channel [34] . NRSF silences NRSE-containing genes in a cell-specific manner and it is expressed in many cells except mature neurons and pancreatic β-cells [28] . NRSF are reported to regulated many G-protein coupled receptors, such as GPR10 [35] , metabotropic glutamate receptor 1 [36] , mu opioid receptor [37, 38] , and AMPA glutamate receptor subunit GluR2 [39] .
In the present study, we demonstrated the repressor effects of NRSF by binding onto the NRSE motif (-83 to -67, hSCTR gene), hence, we proposed here that this mechanism could be responsible for the suppression of SCTR gene in
SCTR-expressing and non-SCTR expressing cells. In this study, we have used the
hSCTR-expressing PANC-1 cell [9, 10] that also expresses NRSF (Western blotting, data not shown). As previous studies [13, 20, 40] , a threshold level of NRSF is required for complete silencing of transcription. As shown here, over expression of NRSF could still reduce hSCTR, suggesting that the endogenous NRSF level in PANC-1 cells is not sufficient to completely silence the hSCTR gene. In summary, in NRSF-expressing PANC-1 cell, the endogenous NRSF level is therefore a key factor in controlling SCTR expression.
Other than the well known gastrointestinal functions of SCT, our recent data also suggested that SCT is potentially a neurohypophysial factor [7] and it is an important central regulators in osmoregulation [8] and appetite control [41] . We showed that the SCTR is expressed in hypothalamus, including the arcuate nucleus (Arc), supraoptic nucleus (SON) and paraventricular nucleus (PVN) [8, 41] . It is interested to note that the expression of NRSF is lower in brain, hypothalamus and pancreatic islets [42] .
The contrary expression pattern between SCTR and NRSF further suggests the role of NRSF in down-regulating the SCTR. It has been shown that the expression of corticotropin-releasing hormone can be reprogramed by the NRSF expression in stress-responsive hypothalamic neurons [43] . Recently, we found that the expression of SCT in hypothalamus was up-regulated by hypertonicity and angiotensin II stimulation [44] . Therefore, the expression of hSCTR may be regulated by similar stimulation through the NRSF in hypothalamus and in other tissues.
Mechanism of NRSF's repressor activity on secretin receptor gene
Recent studies have suggested that the transcriptional repression mediated by NRSF is Sp1-dependent [18] . In our previous works, we showed that Sp1 is a predominant activator, whereas Sp3, itself a weak activator, inhibits hSCTR expression by competing with Sp1 for the same binding sites [10] . As Sp1/Sp3 ratio varies in different cells and also at different stages of the cell cycle [45, 46] , our data indicate the importance of the stochastic ratio of Sp1 and Sp3 in the control of hSCTR gene expression. In the present study, we provided evidence that NRSF could specifically down-regulate Sp1-mediated transactivation. Our data clearly suggested that NRSF interacts with both Sp1 and Sp3 (Figure 4) . Hence, the specificity of NRSF on Sp1 is not likely due to differential interactions. Actually, in a TATA-less promoter such as the hSCTR promoter, Sp1 facilitates binding of transcription factor IID (TFIID) to recruit factors for forming the preinitiation transcriptional complex [47, 48, 49] . It is possible that interactions of NRSF with Sp1 could block the binding of Sp1 with other transcriptional-associated proteins and finally prevent the formation of the preinitiation complex. Alternatively, it has been reported that HDAC could interact with Sp1 to form a silencing complex [50] . Since NRSF recruits HDAC via both the C-and N-termini through Sin3 or CoREST, NRSF could enhance formatting of the silencing complex for histone deacylation or gene silencing [18] . Meanwhile, treatment of an HDAC inhibitor, TSA, relieves the down-regulation of NRSF to Sp1 [40] , suggesting that HDAC is key to the silencer activity of NRSF.
Our data also indicated a specific role of Sp1, but not Sp3, in linking NRSF with HDAC in changing the local chromatin structure for transcriptional down regulation.
This observation is consistent with previous reports showing that a direct interaction of Sp3 and HDAC could not be detected in the two-hybrid system [51] . The difference between the interactions of Sp1 and Sp3 with HDAC may be the key to understand the differential actions of these Sp-proteins on SCTR gene, as well as the secretin receptor super-family expression.
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